Literature DB >> 24811167

The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1.

Xiaming Pang1, Jingjing Zhang2, Hernando Lopez1, Yushu Wang3, Wenyang Li1, Katelyn L O'Neill1, Jacquelynn J D Evans1, Nicholas M George1, Jianhong Long4, Yi Chen1, Xu Luo5.   

Abstract

The BH3-only protein Noxa is a critical mediator of apoptosis and functions primarily by sequestering/inactivating the antiapoptotic Bcl-2 family protein Mcl-1. Although Noxa is a highly labile protein, recent studies suggested that it is degraded by the proteasome in a ubiquitylation-independent manner. In the present study, we investigated the mechanism of Noxa degradation and its ability to regulate the stability of Mcl-1. We found that the ubiquitylation-independent degradation of Noxa does not require a physical association with Mcl-1. A short stretch of amino acid residues in the C-terminal tail was found to mediate the proteasome-dependent degradation of Noxa. Ectopic placement of this degron was able to render other proteins unstable. Surprisingly, mutation of this sequence not only attenuated the rapid degradation of Noxa, but also stabilized endogenous Mcl-1 through the BH3-mediated direct interaction. Together, these results suggest that the C-terminal tail of Noxa regulates the stability of both Noxa and Mcl-1.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  BH3-only Proteins; Bcl-2 Family Proteins; Mcl-1; Mitochondrial Apoptosis; Noxa; Protein Complex; Protein Stability; Ubiquitylation (Ubiquitination)

Mesh:

Substances:

Year:  2014        PMID: 24811167      PMCID: PMC4067213          DOI: 10.1074/jbc.M114.548172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

Review 3.  Cell death in development.

Authors:  D L Vaux; S J Korsmeyer
Journal:  Cell       Date:  1999-01-22       Impact factor: 41.582

4.  Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line.

Authors:  M Hijikata; N Kato; T Sato; Y Kagami; K Shimotohno
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism.

Authors:  Jung-Hwan Yoon; Nathan W Werneburg; Hajime Higuchi; Ali E Canbay; Scott H Kaufmann; Cahit Akgul; Steven W Edwards; Gregory J Gores
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Myeloid cell factor-1 is a critical survival factor for multiple myeloma.

Authors:  Bin Zhang; Ivana Gojo; Robert G Fenton
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

7.  The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.

Authors:  T Schmidt; K Körner; H Karsunky; S Korsmeyer; R Müller; T Möröy
Journal:  Cell Death Differ       Date:  1999-09       Impact factor: 15.828

8.  The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death.

Authors:  Young-Woo Seo; Jin Na Shin; Kang Hee Ko; Jong Hee Cha; Jae Yoon Park; Byoung Rai Lee; Cheol-Won Yun; Young Myeong Kim; Dai-wu Seol; Dong-wook Kim; Xiao-Ming Yin; Tae-Hyoung Kim
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

Review 9.  Ubiquitin-independent proteasomal degradation.

Authors:  Jenny Erales; Philip Coffino
Journal:  Biochim Biophys Acta       Date:  2013-05-14

Review 10.  Cytochrome C-mediated apoptosis.

Authors:  Xuejun Jiang; Xiaodong Wang
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  20 in total

1.  Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin.

Authors:  Bin Cao; Qintong Shi; Wengong Wang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.

Authors:  Weihua Zhou; Jie Xu; Haomin Li; Ming Xu; Zhijian J Chen; Wenyi Wei; Zhenqiang Pan; Yi Sun
Journal:  Clin Cancer Res       Date:  2016-09-02       Impact factor: 12.531

3.  The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes.

Authors:  Vicente Andreu-Fernández; María J García-Murria; Manuel Bañó-Polo; Juliette Martin; Luca Monticelli; Mar Orzáez; Ismael Mingarro
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

4.  PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics.

Authors:  J Cui; W J Placzek
Journal:  Cell Death Differ       Date:  2016-07-01       Impact factor: 15.828

5.  C-Terminal End-Directed Protein Elimination by CRL2 Ubiquitin Ligases.

Authors:  Hsiu-Chuan Lin; Chi-Wei Yeh; Yen-Fu Chen; Ting-Ting Lee; Pei-Yun Hsieh; Domnita V Rusnac; Sung-Ya Lin; Stephen J Elledge; Ning Zheng; Hsueh-Chi S Yen
Journal:  Mol Cell       Date:  2018-05-17       Impact factor: 17.970

6.  BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.

Authors:  Kai Huang; Katelyn L O'Neill; Jian Li; Wei Zhou; Na Han; Xiaming Pang; Wei Wu; Lucas Struble; Gloria Borgstahl; Zhaorui Liu; Liqiang Zhang; Xu Luo
Journal:  Cell Res       Date:  2019-09-24       Impact factor: 25.617

7.  Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

Authors:  Ana Domostegui; Suresh Peddigari; Carol A Mercer; Flavia Iannizzotto; Marta L Rodriguez; Marta Garcia-Cajide; Virginia Amador; Sarah T Diepstraten; Gemma L Kelly; Ramón Salazar; Sara C Kozma; Eric P Kusnadi; Jian Kang; Antonio Gentilella; Richard B Pearson; George Thomas; Joffrey Pelletier
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

8.  Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells.

Authors:  Yi Lun Liu; Fritz Lai; James S Wilmott; Xu Guang Yan; Xiao Ying Liu; Qi Luan; Su Tang Guo; Chen Chen Jiang; Hsin-Yi Tseng; Richard A Scolyer; Lei Jin; Xu Dong Zhang
Journal:  Oncotarget       Date:  2014-11-30

9.  Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450.

Authors:  C Cerella; F Muller; A Gaigneaux; F Radogna; E Viry; S Chateauvieux; M Dicato; M Diederich
Journal:  Cell Death Dis       Date:  2015-06-11       Impact factor: 8.469

10.  High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.

Authors:  Laurel T Bate-Eya; Ilona J M den Hartog; Ida van der Ploeg; Linda Schild; Jan Koster; Evan E Santo; Ellen M Westerhout; Rogier Versteeg; Huib N Caron; Jan J Molenaar; M Emmy M Dolman
Journal:  Oncotarget       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.